Intuitive Surgical, Inc. (ISRG) key performance indicators and operating metrics (15 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Instruments and Accessories Revenue | 1.73B | FY2026-Q2 |
| Net Income Attributable to Intuitive Surgical, Inc. (Non-GAAP) | 1B | FY2026-Q2 |
| Systems Revenue | 685M | FY2026-Q2 |
| Services Revenue | 472.4M | FY2026-Q2 |
| Da Vinci Surgical System Placements | 468.00 | FY2026-Q2 |
| Income from Operations (GAAP) | 971.9M | FY2026-Q2 |
| Income from Operations (Non-GAAP) | 1.22B | FY2026-Q2 |
| Da Vinci Surgical System Installed Base | 11.71K | FY2026-Q2 |
| Da Vinci 5 Surgical System Placements | 246.00 | FY2026-Q2 |
| Da Vinci Procedures Growth | 15.00 percent | FY2026-Q2 |
| Ion Endoluminal System Installed Base | 1.1K | FY2026-Q2 |
| ION Procedures Growth | 36.00 percent | FY2026-Q2 |
| Ion Endoluminal System Placements | 55.00 | FY2026-Q2 |
| Diluted Earnings per Share (Non-GAAP) | 2.50 USD_per_share | FY2026-Q1 |
Back to ISRG overview · ISRG earnings · ISRG holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.